Oxytocin - Oxytone Bioscience
Alternative Names: 14C-labelled oxytocin; Orally disintegrating oxytocin - Oxytone BioscienceLatest Information Update: 04 Dec 2021
At a glance
- Originator Oxytone Bioscience
- Class Amides; Amines; Analgesics; Antihaemorrhagics; Antihyperglycaemics; Antimigraines; Behavioural disorder therapies; Hormones; Macrocyclic lactams; Obesity therapies; Oxytocics; Pyrrolidines
- Mechanism of Action Oxytocin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Postpartum haemorrhage
Most Recent Events
- 28 May 2021 No recent reports of development identified for phase-I development in Postpartum haemorrhage (In volunteers) in Sweden (IV)
- 28 May 2021 No recent reports of development identified for phase-I development in Postpartum haemorrhage (In volunteers) in Sweden (PO, Tablet)
- 28 May 2020 No recent reports of development identified for preclinical development in Postpartum haemorrhage in Netherlands (PO, Tablet)